Abhay A. Singh

Hypomethylating agents (HMA) treatment for myelodysplastic syndromes: alternatives in the frontline and relapse settings

S. Gore, T. Prebet, N. Uy, 2017, Expert opinion on pharmacotherapy.

Outcomes of Adult Acute Myeloid Leukemia Treated With Gemtuzumab-Ozogamicin: Cue To Optimized Chemotherapy Backbone.

K. Attwood, S. Thota, E. Wang, 2021, Clinical lymphoma, myeloma & leukemia.

From clonal hematopoiesis to myeloid leukemia and what happens in between: Will improved understanding lead to new therapeutic and preventive opportunities?

S. Halene, J. Bewersdorf, A. Zeidan, 2019, Blood reviews.

Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions

Inderpreet Singh, Abhay A. Singh, 2023, Current Oncology Reports.

Emerging trends of therapy related myeloid neoplasms following modern cancer therapeutics in the United States

S. Thota, T. Hahn, E. Wang, 2021, Scientific Reports.

Predictors of vascular disease in myelodysplastic syndromes

S. Thota, E. Wang, E. Griffiths, 2020, EJHaem.